Parabiosis and cross-circulation experiments with spontaneously hypertensive and normotensive rats gave indicatiohs for a previously unidentified circulating hypertensive agent. In this study, plasma from normotensive and hypertensive rats was fractionated and the vasopressor action of the corresponding fractions was measured in the isolated perfused rat kidney. One of three vasoactive fractions obtained by gel filtration (Biol-Gel P2) from hypertensive rats showed a significantly higher activity (increase in perfusion pressure by 1502.9 2 438.9 Pa) than that from normotensive rats (increase in perfusion pressure by 505.4 ? 186.2 Pa, P < 0.01). Further chromatographic separations of this fraction revealed that the hypertensive factor is hydrophilic and has no ionic groups or vicinal diol groups. The molecular mass was estimated by dialysis and the matrix-assisted laser desorptiodionization mass spectrometry to be in the range of 1 kDa. The vasopressor is heat resistant and not degradable with trypsin or carboxypeptidase Y. The vasopressor action was not inhibited with the angiotensin-11-receptor antagonist saralasin, the a-receptor antagonist phentolamine, the thromboxane-receptor antagonist carbocyclic thromboxane A, or the serotonin antagonist ketanserine.The results confirm the existence of a vasopressor factor in the plasma of hypertensive rats and, in a lower concentration, of normotensive rats, which is possibly related to the pathogenesis of essential hypertension. The chromatographic behaviour suggests that this factor is different from the parathyroid hypertensive factor described recently.In primary hypertension, as yet unidentified circulating vasoconstrictor substances have long been postulated [l -61 ; recently, endogenous ouabain was isolated from human plasma [7]. In spontaneously hypertensive rats (SHR), a new approach to this problem was made with the observation that the parathyroid glands secrete a hypertensive factor [S], which is not found in the normotensive Wistar-Kyoto rats (WKY). In the Munster strain of SHR, hypertension could be transmitted to WKY by cross-circulation [9]. Therefore, in the present study, the chromatograpic characteristics and the isolation procedure of the underlying substance are described and compared with those of the 'parathyroid hypertensive factor' [lo]. It was found that our isolation procedure revealed a low-molecular-mass hydrophilic, non-peptide substance, which is not identical with the parathyroid hypertensive factor nor with ouabain.
MATERIALS AND METHODS MaterialsBiol-Gel P2 (200-400-mesh, fine : Bio-Rad), norepinephrine hydrochloride, phentolamine hydrochloride, serotonin hydrochloride (5-hydroxytryptamine), angiotensin I1 acetate, carbocyclic thromboxane A, and the other agents used were purchased from Sigma, except the thromboxane receptor blocker, daltroban [ 11 -131, which was kindly provided by Boehringer Mannheim and ketanserin tartrate, a serotonin receptor blocker also inhibiting a,-adrenoceptors in high concentrations [14], which was supplie...